why are there so many glp 1 drugs GLP-1 Medications: Everything You Need to Know The GLP-1 Access Gap: Mapping

See Supplementary Table 1 for siRNA target sequences

Roche Holding AG Merck & Co

Based on the results of this study, Novo Nordisk developed "semaglutide," a GLP-1 analog that stays in the body for a week

Future Outlook: Pfizer is currently focusing on a once-daily formulation with the hope of reducing side effects and improving tolerability

Large-scale clinical trials, including the SELECT cardiovascular outcome trial with over 17,000 participants, have not demonstrated increased overall cancer incidence with these medications compared to placebo groups

Over the past decade, it has been demonstrated that myocardial structure, cardiomyocyte function, and intramyocardial signaling undergo specific alterations in heart failure with preserved ejection fraction (HFpEF)